检索历史清除

首页> Blood: The Journal of the American Society of Hematology> Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity

Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity

导出原文传递

翻译打印收藏纠错

作者： Bacher,U. ^[1] ; Schnittger,S. ^[2] ; Macijewski,K. ; Grossmann,V. ; Kohlmann,A. ; Alpermann,T. ; Kowarsch,A. ; Nadarajah,N. ; Kern,W. ; Haferlach,C. ; Haferlach,T.

作者单位： MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377 Munich, Germany ^[1] Department for Stem Cell Transplantation, University of Hamburg, Germany ^[2]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交